Edition:
India

People: Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

143.68USD
25 Nov 2020
Change (% chg)

-- (--)
Prev Close
$143.68
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,012,006
52-wk High
$157.00
52-wk Low
$109.17

Wolk, Joseph 

Mr. Joseph J. Wolk is Chief Financial Officer, Executive Vice President of the Company. He was previously Vice President, Group Finance for the Pharmaceuticals Group of Johnson & Johnson, where he provided finance leadership, supporting Worldwide Chairman, Pharmaceuticals Joaquin Duato, and Chief Scientific OfficerPaul Stoffels, as a member of the Pharmaceuticals Group Operating Committee. Prior to that role, he held other finance leadership positions at Johnson & Johnson as Vice President of Finance for the Medical Devices Global Supply Chain, and as Chief Financial Officer of the North America Pharmaceuticals Group, responsible for Centocor Ortho Biotech Inc. as well as U.S. Pricing Strategy and Compliance. Wolk joined Johnson & Johnson in 1998 as a Finance Manager in the Ortho-McNeil Pharmaceutical organization. Prior to joining Johnson & Johnson, Wolk held multiple positions of increasing responsibility at Ametek, Inc. He holds a Bachelor of Science degree in Finance from St. Joseph's University, where he currently serves on the Haub School of Business Board of Visitors, and he also holds a Juris Doctor degree from Temple University School of Law and is a Certified Public Accountant.

Basic Compensation

Total Annual Compensation, USD 1,929,450
Restricted Stock Award, USD 2,379,420
Long-Term Incentive Plans, USD --
All Other, USD 3,188,820
Fiscal Year Total, USD 7,497,690

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Alex Gorsky

25,365,800

Paulus Stoffels

14,067,800

Joaquin Duato

13,419,300

Joseph Wolk

7,497,690

Peter Fasolo

3,621,280

Michael Ullmann

5,336,150
As Of  31 Dec 2019